WU
32
2
MLM
57
6
HD
57
2
HP
48
3
CPB
30
6
DE
63
3
CHRW
56
-3
DFS
64
2
PBI
69
4
SE
61
-4
NWL
53
3
MA
64
7
ADBE
49
3
LLY
37
-3
INTC
33
-2
LMT
34
2
NVDA
56
-4
NKE
36
6
ADT
53
3
TDC
80
4
WU
32
2
MLM
57
6
HD
57
2
HP
48
3
CPB
30
6
DE
63
3
CHRW
56
-3
DFS
64
2
PBI
69
4
SE
61
-4
NWL
53
3
MA
64
7
ADBE
49
3
LLY
37
-3
INTC
33
-2
LMT
34
2
NVDA
56
-4
NKE
36
6
ADT
53
3
TDC
80
4
Financhill
Back

SELLAS Life Sciences Group 10K Form

Sell
47

SLS
SELLAS Life Sciences Group

Last Price:
1.17
Seasonality Move:
12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SLS News And Ratings

See the #1 stock for the next 7 days that we like better than SLS

SLS Financial Statistics

Sales & Book Value

Annual Sales: $1M
Cash Flow: $-7.81M
Price / Cash Flow: 0
Annual Sales: $0.25
Price / Book: 5.18

Profitability

EPS (TTM): -0.69000
Net Income (TTM): $-32.28M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

SELLAS Life Sciences Group Earnings Forecast

Key SELLAS Life Sciences Group Financial Ratios

  • The Selling, General & Administrative Expenses for SLS have been equal to 1,258.20% of Gross Profit Margin.
  • The Interest Expense is -0.98% of Operating Income.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

SELLAS Life Sciences Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SLS
CUSIP: 81642T
Website: sellaslifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SLS Technical Analysis vs Fundamental Analysis

Sell
47
SELLAS Life Sciences Group (SLS) is a Sell

Is SELLAS Life Sciences Group a Buy or a Sell?